Apparatus and method for measuring physiological characteristics of an intact trachea in vitro by Fedan, Jeffrey & Van Scott, Michael
(12) United States Patent 
Fedan et al. 
US007907999B2 
US 7,907,999 B2 
Mar. 15, 2011 
(10) Patent No.: 
(45) Date of Patent: 
(54) APPARATUS AND METHOD FOR 
MEASURING PHYSIOLOGICAL 
CHARACTERISTICS OF AN INTACT 
TRACHEAN VITRO 
(75) Inventors: Jeffrey S. Fedan, Morgantown, WV 
(US); Yi Jing, Morgantown, WV (US); 
Michael Van Scott, Greenville, NC (US) 
(73) Assignees: The United States of America as 
represented by the Secretary of the 
Department of Health and Human 
Services, Washington, DC (US); East 
Carolina University, Greenville, NC 
(US); Centers for Disease Control and 
Prevention, Atlanta, GA (US) 
(*) Notice: Subject to any disclaimer, the term of this 
patent is extended or adjusted under 35 
U.S.C. 154(b) by 887 days. 
(21) Appl. No.: 11/655,635 
(22) Filed: Jan. 19, 2007 
(65) Prior Publication Data 
US 2007/O 170928A1 Jul. 26, 2007 
Related U.S. Application Data 
(60) Provisional application No. 60/762.465, filed on Jan. 
25, 2006. 
(51) Int. Cl. 
A6IB5/05 (2006.01) 
(52) U.S. Cl. ........................................ 600/547; 600/560 
(58) Field of Classification Search ................... 6OO/547 






(56) References Cited 
U.S. PATENT DOCUMENTS 
4,245,643 A 1/1981 Benzing, III et al. 
5,063,937 A 11/1991 Ezenwa et al. 
5,397.452 A 3, 1995 Bucket al. 
5.490,916 A 2, 1996 Hall 
5,833,825 A 11/1998 Otten et al. 
6,465,205 B2 10/2002 Hicks, Jr. 
6,823,212 B2 11/2004 Pinyayev 
6,865,409 B2 3/2005 GetSla et al. 
6,922.586 B2 7/2005 Davies 
(Continued) 
FOREIGN PATENT DOCUMENTS 
WO WO99,48422 9, 1999 
OTHER PUBLICATIONS 
Y. Jing etal. “Epithelial bioelectric and muscle mechanical effects of 
pharmacological agents in a newly-developed guinea-pig isolated 
trachea perfusion apparatus.” 
(Continued) 
Primary Examiner — Max Hindenburg 
Assistant Examiner — Michael C Stout 
(74) Attorney, Agent, or Firm — Klarduist Sparkman, LLP 
(57) ABSTRACT 
Apparatus and methods for measuring Smooth muscles 
responses (relaxation and contraction), transepithelial poten 
tial difference, and/or transepithelial impedance of an intact 
trachea in vitro. In particular embodiments, the apparatus 
includes a perfusion device on which an extracted, intact 
trachea is mounted. The perfusion device and the trachea are 
immersed in an extraluminal bath, which is isolated from the 
perfusion liquid flowing through the trachea. A set of voltage 
sensing electrodes is provided for measuring the transepithe 
lial potential difference across the trachea wall. A set of 
current electrodes is provided for inducing an electrical cur 
rent to flow across the trachea wall in order to determine 
transepithelial impedance. 
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1. 
APPARATUS AND METHOD FOR 
MEASURING PHYSIOLOGICAL 
CHARACTERISTICS OF AN INTACT 
TRACHEAN VITRO 
CROSS-REFERENCE TO RELATED 
APPLICATION 
The present application claims the benefit of U.S. Provi 
sional Application No. 60/762,465, filed Jan. 25, 2006, which 
is incorporated herein by reference. 
ACKNOWLEDGMENT OF GOVERNMENT 
SUPPORT 
This invention was made by The National Institute for 
Occupational Safety and Health, Centers for Disease Control 
and Prevention, an agency of the United States Government. 
FIELD 
The present invention concerns an apparatus and method 
for measuring physiological characteristics of an intact tra 
chea in vitro, and in particular, simultaneously measuring 
epithelial bioelectric properties and muscle responses of the 
trachea. 
BACKGROUND 
Investigation of the mechanisms of lung diseases, such as 
asthma and cystic fibrosis, involves understanding the roles of 
the smooth muscle and the epithelium of the airway (trachea). 
The smooth muscle controls the airway diameter, while the 
epithelium regulates ionic composition of the liquid lining the 
airway through electrogenic ion transport and releases factors 
that regulate the ability of the smooth muscle to contract. 
Various techniques and apparatus are known for stimulating 
an intact trachea or a tracheal segment in vitro and for mea 
Suring Smooth muscle activity and bioelectric properties of 
the epithelium in response to the stimuli. 
One known technique for measuring the contraction and 
relaxation of the airway Smooth muscle involves mounting an 
intact trachea to a perfusion device for flowing a perfusion 
liquid through the trachea. The perfusion device has an inlet 
cannula extending into one end of the trachea and an outlet 
cannula extending into the opposite end of the trachea. A 
differential pressure device fluidly connected to the cannulas 
measures the differential pressure of the perfusion liquid 
flowing through the trachea (e.g., the inlet pressure minus the 
outlet pressure), which is a direct index of the airway diam 
eter. The inner epithelial surface or the outer serosal surface is 
stimulated by adding agents to the perfusion liquid or an 
extraluminal bath in which the trachea is disposed. The dif 
ferential pressure device is used to detect changes in the 
airway diameter in response to the stimuli. A drawback of this 
technique is that there is no provision for measuring bioelec 
tric properties of the epithelium, Such as the electrical poten 
tial across the epithelium (transepithelial potential differ 
ence) and the impedance of the epithelium (transepithelial 
impedance). 
In an improvement of the foregoing technique, the perfu 
sion device and trachea are placed in an extraluminal bath 
containing a Voltage electrode. Another Voltage electrode is 
placed in the perfusion line Supplying the perfusion liquid to 
the trachea. The voltage electrodes are used to measure the 
transepithelial potential difference of the trachea. As 













measure the differential pressure of the perfusion liquid flow 
ing through the trachea. While an improvement of prior 
devices, this technique Suffers from the disadvantage that 
there is no provision for measuring the transepithelial imped 
ance of the trachea. 
A common technique for simultaneously measuring the 
transepithelial potential and transepithelial impedance of a 
trachea involves placing a Small, flattened strip of trachea in 
an in vitro apparatus known as an “Ussing chamber. The 
chamber has separate ports for connecting Voltage electrodes 
and current electrodes. The Voltage electrodes measure the 
transepithelial potential difference of the trachea segment, 
while the current electrodes pass a current through the trachea 
segment to permit measurement of the transepithelial imped 
ance. Unfortunately, this technique cannot be used for mea 
suring smooth muscle activity of the trachea. Moreover, the 
cylindrical tracheal wall becomes distorted when it is flat 
tened and clamped inside the Ussing chamber. 
Heretofore, prior devices have not allowed for the mea 
Surement of Smooth muscle activity, transepithelial potential 
difference and transepithelial impedance of a single trachea 
preparation. Accordingly, there is a continuing need for 
improved apparatus and methods for measuring characteris 
tics of a trachea. 
SUMMARY 
The present disclosure concerns an apparatus and methods 
for simultaneously measuring Smooth muscles responses (re 
laxation and contraction), transepithelial potential difference, 
and/or transepithelial impedance of an intact trachea in vitro. 
In particular embodiments, the apparatus includes a perfusion 
device on which an extracted, intact trachea is mounted. The 
perfusion device allows the trachea to be extended to its 
original, in situ length, and is configured to establish a flow of 
perfusion liquid through the lumen of the trachea. The perfu 
sion device and the trachea are immersed in an extraluminal 
bath, which is isolated from the perfusion liquid flowing 
through the trachea. 
A set of Voltage-sensing electrodes is provided for measur 
ing the transepithelial potential difference across the trachea 
wall. The set of Voltage-sensing electrodes includes at least a 
first Voltage-sensing electrode placed in electrical continuity 
with the perfusion liquid in the trachea and a second Voltage 
sensing electrode immersed in the extraluminal bath. A set of 
current electrodes is provided for inducing an electrical cur 
rent to flow across the trachea wall. The set of current elec 
trodes includes at least a first current electrode placed in 
electrical continuity with the perfusion liquid flowing into the 
trachea and a second current electrode immersed in the 
extraluminal bath. 
The perfusion device also can include first and second 
cannulas inserted into the opposite ends of the trachea. The 
cannulas are fluidly connected to the ports of a differential 
pressure transducer to permit measurement of the pressure 
drop of the perfusion liquid flowing through the trachea. The 
pressure drop is a direct index of airway diameter, and hence 
is a measurement of Smooth muscle relaxation and contrac 
tion. 
In use and under open circuit conditions, the current elec 
trodes pass an electrical current through the trachea wall and 
the Voltage-sensing electrodes detect the changes in the tran 
sepithelial potential difference. Alternatively, the device can 
be used in a “voltage clamp' (short circuit) mode where 
calibrated Voltage pulses are applied across the trachea wall 
and the changes in short circuit current are measured. Apply 
ing Ohm’s Law, the transepithelial impedance can be calcu 
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lated from the changes in potential difference (using applied 
current under open circuit conditions) or from the changes in 
short circuit current (using applied Voltage under Voltage 
clamp conditions). An agent can be added to the intraluminal 
perfusion liquid and/or to the extraluminal bath to evaluate its 
effect on smooth muscle activity and the transepithelial 
potential difference and impedance. 
Because an agent can be introduced into the trachea lumen, 
where it must first traverse the epithelium to reach the smooth 
muscle, or to the outside of the trachea, where there is no 
hindrance of agents to the Smooth muscle, the apparatus 
permits evaluation of the functional integrity of the epithe 
lium using pharmacological techniques. The apparatus also 
permits efficient Screening of the effects of agents and drugs 
on airway epithelium and Smooth muscle in the same prepa 
ration. 
The foregoing and other objects, features, and advantages 
of the invention will become more apparent from the follow 
ing detailed description, which proceeds with reference to the 
accompanying figures. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a schematic diagram of an apparatus for measur 
ing physiological characteristics of an intact trachea in vitro, 
according to one embodiment. 
FIG. 2 is a perspective view of the perfusion device used in 
the apparatus of FIG. 1 for mounting the trachea. 
FIG. 3 is a cross-sectional view of the perfusion device 
taken along line 3-3 of FIG. 2. 
FIG. 4 is a cross-sectional view of the perfusion device 
taken along line 4-4 of FIG. 2. 
FIG.5 is a “flattened cross-sectional view of the perfusion 
device taken along section 5-5 of FIG. 3. 
FIG. 6 is a “flattened cross-sectional view of the perfusion 
device taken along section 6-6 of FIG. 4. 
FIG. 7 is an enlarged, fragmentary view of the perfusion 
device, extraluminal Voltage electrode, and extraluminal cur 
rent electrode of the apparatus shown in FIG. 1. 
FIGS. 8A and 8B are data plots showing the effects of 
amiloride and NPPB, respectively, on the transepithelial 
potential difference (V) of a trachea. The vertical lines 
extending above the data plots show the Voltage excursions in 
response to the application of a calibrated current across the 
trachea wall. 
FIGS. 9A to 9D are bar graphs summarizing the effects of 
amiloride and NPPB on V, and the transepithelia impedance 
(R) of the trachea. 
FIGS. 10A and 10B are data plots showing the effects of 
ouabain and bumetanide, respectively, on the differential 
pressure (AP) of the trachea. 
FIGS. 10C and 10D are data plots showing the effects of 
ouabain and bumetanide, respectively, on V, of the trachea. 
The vertical lines extending above the data plots show the 
Voltage excursions in response to the application of a cali 
brated current across the trachea wall. 
FIGS. 11A to 11D are bar graphs summarizing the effects 
of ouabain and bumetanide on V, and R, of the trachea. 
FIGS. 12A and 12B are data plots showing the effects of 
histamine and terbutaline, respectively, on AP of the trachea. 
FIGS. 12C and 12D are data plots showing the effects of 
histamine and terbutaline, respectively, on V, of the trachea. 
The vertical lines extending above the data plots show the 
Voltage excursions in response to the application of a cali 
brated current across the trachea wall. 
FIGS. 13 A-13D are bar graphs summarizing the effects of 













FIGS. 14A and 14B are data plots showing the effects of 
hyperosmolarity elicited with NaCl and D-M, respectively, 
on AP of the trachea. 
FIGS. 14C and 14D are data plots showing the effects of 
hyperosmolarity elicited with NaCl and D-M, respectively on 
V, of the trachea. The vertical lines extending above the data 
plots show the Voltage excursions in response to the applica 
tion of a calibrated current across the trachea wall. 
FIGS. 15A-15D are bar graphs summarizing the effects of 
hyperosmolarity elicited with NaCl and D-M on V, and R, of 
the trachea. 
DETAILED DESCRIPTION 
As used herein, the singular forms “a,” “an and “the refer 
to one or more than one, unless the context clearly dictates 
otherwise. 
As used herein, the term “includes” means “comprises.” 
For example, a device that includes or comprises A and B 
contains A and B but may optionally contain C or other 
components other than A and B. A device that includes or 
comprises A or B may contain A or B or A and B, and 
optionally one or more other components such as C. 
As used herein, an "agent” refers to any composition or 
Substance that affects a biological function of a subject or 
organ (or part thereof) to which it is administered (in vivo or 
in vitro). An example of an agent is a pharmaceutical agent, 
Such as a drug orantibiotic, which is given to a subject to alter 
a physiological condition of the Subject or organ, Such as a 
disease. 
As used herein, the term "drug includes any agent admin 
istered for a therapeutic (including diagnostic) or research 
purpose. 
As used herein, an "intact’ trachea refers to a whole trachea 
or a tracheal segment having its in situ shape and structure 
defining a lumen through which a perfusion liquid can flow. 
In accordance with one embodiment, FIG. 1 shows an 
apparatus for measuring physiological characteristics of an 
intact trachea in vitro, indicating generally at 10. The appa 
ratus 10 in the illustrated embodiment generally includes a 
perfusion device 12 for mounting an intact trachea 14, a 
differential pressure transducer 16, a Voltage/current clamp 
amplifier 18 (or equivalent instrumentation), a heat 
exchanger 20, a bubble trap 22, a pump 24, a vessel 26 
containing an intraluminal perfusion liquid, and a vessel 28 
containing the perfusion device. A perfusion circuit for flow 
ing a perfusion liquid (e.g., a physiological salt solution) 
through the trachea 14 is formed by the perfusion device 12, 
the heat exchanger 20, the bubble trap 22, the pump 24, and 
the vessel 26. The perfusion device 12 and the trachea 14 are 
disposed in an extraluminal bath 54 contained in vessel 28. 
Desirably, vessel 28 contains a sufficient volume of liquid 54 
to completely submerge the trachea 14 (although it is not 
required to completely Submerge the perfusion device 12). 
The trachea 14 can be a whole or substantially whole trachea 
or a portion of a trachea that defines a lumen (i.e., the trachea 
has not been cut lengthwise and flattened). Vessels 26, 28 can 
be jacketed type vessels having an outerjacket configured to 
receive a heating fluid (e.g., water) for maintaining the per 
fusion liquid and the extraluminal bath at a desired tempera 
ture. 
In use, perfusion liquid 32 from vessel 26 is circulated 
through the perfusion circuit by the pump 24 in the direction 
of arrows 30. Agents can be added to the perfusion liquid 32 
(via vessel 26) and/or to the extraluminal bath 54 in vessel 28 
to evaluate or measure their bioelectric and/or mechanical 
effects on the trachea. Examples of such agents include, with 
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out limitation, ion channel blockers (e.g., amiloride and 
NPPB), ion transport inhibitors (e.g., ouabain and bumet 
anide), receptoragonists (e.g., histamine and terbutaline), and 
osmolytes (e.g., NaCl and D-mannitol (D-M)). The heat 
exchanger 20 is used to heat the perfusion liquid to a desired 
temperature prior to entering the trachea. The bubble trap 22 
removes any air bubbles from the perfusion circuit. 
The perfusion device 12 includes a first, perfusion liquid 
inlet conduit 34 for introducing perfusion liquid from the 
perfusion circuit into the trachea 14, a second, perfusion 
liquid outlet conduit 36 for discharging perfusion liquid from 
the perfusion device 12, a third conduit 38, and a fourth 
conduit 40. The first conduit 34 is fluidly connected to the 
perfusion circuit by a conduit 42 that is connected to the outlet 
of the heat exchanger 20. The second conduit 36 is fluidly 
connected to the perfusion circuit by a conduit 44 that intro 
duces circulating perfusion liquid into vessel 26. Thus, per 
fusion liquid from the heat exchanger 20 is caused to flow 
through conduit 42, inlet conduit 34, the trachea 14, discharge 
conduit 36, conduit 44 and into vessel 26. 
A first port 50 of the differential pressure transducer 16 is 
in fluid communication with the inlet of the trachea 14 by the 
third conduit 38 of the perfusion device and a conduit 46. A 
second port 52 of the differential pressure transducer 16 is in 
fluid communication with the outlet of the trachea 14 by the 
fourth conduit 40 and a conduit 48. As described in greater 
detail below, this arrangement allows the differential pressure 
transducer 16 to measure a pressure difference of the perfu 
sion liquid flowing through the trachea 14. 
As further shown in FIG. 1, the apparatus 10 also includes 
a set of voltage-sensing electrodes for measuring the transepi 
thelial potential difference of the trachea 14. The set of volt 
age-sensing electrodes in the illustrated embodiment includes 
at least a first Voltage-sensing electrode (V) 56 extending 
into conduit 46 so as to be in electrical continuity with the 
perfusion liquid therein and a second Voltage-sensing elec 
trode (V) 58 disposed in the extraluminal bath 54. The volt 
age-sensing electrodes 56,58 are electrically connected to the 
amplifier 18. The voltage-sensing electrodes 56, 58 can be 
conventional half-cell electrodes, such as flowing or non 
flowing half-cell electrodes, in continuity through a physi 
ological salt solution bridge. For example, the Voltage-sens 
ing electrodes 56, 58 can be conventional silver/silver 
chloride electrodes (for example, model EKC Voltage 
electrodes from World Precision Instruments, Sarasota, Fla., 
or equivalent voltage electrodes available from Warner 
Instruments, Hamden, Conn.). 
The apparatus 10 also includes a set of current electrodes 
for applying a current across the trachea wall. The set of 
current electrodes in the illustrated embodiment includes at a 
first current electrode (I) 60 extending into conduit 42 so as 
to be in electrical continuity with the perfusion liquid flowing 
into the trachea 14 and a second current electrode (I) 62 
disposed in the extraluminal bath 54. The first current elec 
trode 60 can be a conventional half-cell electrode, such as a 
conventional silver/silver-chloride electrode (for example, 
model EKC voltage electrodes from World Precision Instru 
ments, Sarasota, Fla., or equivalent Voltage electrodes avail 
able from Warner Instruments, Hamden, Conn.). The second 
current electrode 62 desirably completely surrounds the tra 
chea 14 and the second Voltage-sensing electrode 58, and can 
be made of any suitable, preferably non-toxic, electrically 
conductive material. Such as a metal or metal alloy. In par 
ticular embodiments, for example, the second current elec 
trode 62 comprises a cylindrical platinum screen. 
Referring to FIG. 7, the perfusion device 12 includes an 














from and aligned with the inlet portion 64. The inlet portion 
64 is formed with a stepped outer surface 68 and the outlet 
portion 66 is formed with a stepped outer surface 70. A first 
end portion 72 of the trachea 14 extends over the stepped 
surface 68 and can be secured to the inlet portion 64 by a piece 
of string tied tightly around the trachea 14 at the stepped 
surface 68. Likewise, a second end portion 74 of the trachea 
14 extends over stepped surface 70 and can be secured to the 
outlet portion 66 by a piece of string 76 tied tightly around the 
trachea at the stepped surface 70. 
Referring also to FIGS. 2-6, a first cannula 78 extends 
coaxially through the inlet portion 64 and has a distal end 
portion 80 extending outwardly from the inlet portion 64 and 
into the first end portion 72 of the trachea 14. The first cannula 
78 is formed with a lumen 94 (FIGS. 3 and 5) and two 
openings 82 on opposite sides of the distal portion 80 (one of 
which is shown in FIGS. 2 and 5), which open the lumen 94 
to the perfusion liquid in the trachea for measuring the pres 
Sure of the liquid at that location. A second cannula 84 extends 
coaxially through the outlet portion 66 and has a distal end 
portion 86 extending outwardly from the outlet portion 66 and 
into the second end portion 74 of the trachea 14. The second 
cannula 84 is formed with a lumen98 (FIGS. 4 and 6) and two 
openings 88 on opposite sides of the distal portion 86 (one of 
which is shown in FIGS. 2 and 6), which open the lumen 98 
to the perfusion liquid in the trachea for measuring the pres 
Sure of the liquid at that location. 
As best shown in FIGS. 5 and 7, inlet conduit 34 extends 
into a first manifold 104 and is fluidly connected to a bore, or 
passageway, 90 formed in the manifold 104. The bore 90 in 
turn is fluidly connected to the inlet portion 64. An inlet flow 
path for the perfusion liquid 32 flowing into the trachea 14 
therefore is defined by bore 90 and the area between the outer 
surface of the first cannula 78 and the inside surface of the 
inlet portion 64. A removable screw 106 (FIGS. 3 and 5) is 
inserted into a threaded opening that is formed in the side of 
the manifold 104 and opens into the bore 90. The screw 106 
can be removed from the manifold 104 for flushing and clean 
ing the device. 
As best shown in FIG. 5, a tube 108 extends from the bore 
90 opposite the inlet portion 64 and outwardly from the first 
manifold 104. Conduit 38 extends through the first manifold 
104 and has a lower end portion 110 adjacent tube 108. The 
first cannula 78 has a proximal end portion 92 that extends 
through tube 108 and into a tube 100. Tube 100 has one end 
portion fluidly connected to tube 108 and another end portion 
fluidly connected to the lower end portion 110 of conduit 38. 
The proximal end of the first cannula 78 is open so that fluid 
in the trachea 14 can flow through openings 82, lumen 94. 
tube 100, conduit 38, and to the first port 50 of the differential 
pressure transducer 16 (FIG. 1). Tube 100 is compressed 
against the first cannula 78 below the inlet portion 64 to form 
a circumferential seal around the cannula, preventing perfu 
sion liquid flowing into the inlet portion 64 from flowing 
directly into tube 100. This can be accomplished by tying a 
string or wire 136 around tubing 100, causing it to compress 
against the outer surface of the cannula 78. A relatively stiffer 
inner tube 102 can be positioned inside tube 100 to maintain 
tube 100 in an open bore configuration. 
As best shown in FIG. 6, outlet conduit 36 extends into a 
second manifold 112 and is fluidly connected to a bore, or 
passageway, 114 formed in the manifold 112. The bore 114 in 
turn is fluidly connected to the outlet portion 66. An outlet 
flow path for the perfusion liquid32 flowing out of the trachea 
14 therefore is defined by the area between the outer surface 
of the second cannula 84 and the inside surface of the outlet 
portion 66. A removable screw 116 (FIGS. 4 and 6) is inserted 
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into a threaded opening that is formed in the side of the second 
manifold 112 and opens into the bore 114. The screw 116 can 
be removed from the manifold 112 for flushing and cleaning 
the device. 
Mounted adjacent the second manifold 112 is an adjust 
ment mechanism 118 that is operable to adjust the spacing 
between the inlet and outlet portions 64, 66. Conduits 34 and 
38 extend through the second manifold 112 and the adjust 
ment mechanism 118. Outlet conduit 36 extends outwardly 
from the manifold 112 and through the adjustment mecha 
nism 118. Conduit 40 extends through the adjustment mecha 
nism 118 and has a lower end portion connected to a tube 120 
between the adjustment mechanism 118 and the manifold 
112. Tube 120 extends from bore 114 opposite the outlet 
portion 66 and outwardly from the manifold 112. 
The adjustment mechanism 118 is maintained at a fixed 
position relative to the manifold 112 but is slidable relative to 
conduits 34, 36, 38, and 40. Additionally, manifold 112 is 
slidable relative to conduits 34 and 38. Hence, the adjustment 
mechanism 118 and manifold 112 can be moved longitudi 
nally toward and away from manifold 104, as indicated by 
double-headed arrow 124, so as to increase or decrease the 
distance between the inlet portion 64 and the outlet portion 66 
to accommodate tracheas of varying lengths. In this manner, 
the trachea 14 can be secured to the inlet and outlet portions 
64, 66 and extended to its in situ length. 
One or more set screws 126, 128 (FIG. 2) can be provided 
to fix the position of the adjustment mechanism 118 relative 
to conduits 34, 36, 38, and 40. Screw 126 extends into a 
threaded opening in the adjustment mechanism 118 and bears 
against conduit 36. Similarly, screw 128 extends into a 
threaded opening in the adjustment mechanism 118 and bears 
against conduit 38. Tightening the Screws 126, 128 against 
conduits 36, 38, respectively, retains the adjustment mecha 
nism 118 and manifold 112 at fixed location relative to the 
inlet portion 64, while loosening the screws allows adjust 
ment of the adjustment mechanism 118 and manifold 112. 
As best shown in FIG. 6, the second cannula 84 extends 
coaxially through tube 120 and conduit 40. The proximal end 
of the second cannula 84 is open so that fluid in the trachea 14 
can flow through openings 88, lumen 98, conduit 40, and to 
the second port 52 of the differential pressure transducer 16 
(FIG. 1). Conduit 40 is compressed against the second can 
nula 84 on opposite sides of the adjustment 118 to form 
circumferential seals around the cannula 84, preventing per 
fusion liquid flowing out of the outlet portion 66 from flowing 
directly into conduit 40. This can be accomplished by tying a 
string or wire 138 around tubing 122 at one or more locations 
as shown in the illustrated embodiment, causing it to com 
press against the outer Surface of the cannula 84. 
As described above, the first port 50 of the differential 
pressure transducer 16 is in fluid communication with the 
openings 82 in the first cannula 78 and the second port 52 of 
the differential pressure transducer 16 is in fluid communica 
tion with the openings 88 in the second cannula 84. As a 
result, the differential pressure transducer 16 “sees the pres 
sure of the perfusion liquid flowing through the trachea 14 at 
the openings 82 and 88 and can calculate the pressure drop 
(AP) of the perfusion liquid between these two locations (as 
depicted in FIG. 7). The pressure drop is a direct index of the 
airway diameter when the trachea is perfused at a constant 
flow, and hence is a measure of Smooth muscle relaxation or 
contraction. 
Other types of differential pressure devices also can be 
used to determine AP. In one embodiment, for example, each 
of the cannulas 78, 84 can be fluidly connected to a respective 













pressure at a location in the trachea and AP is calculated from 
these measurements. In other embodiments, a mechanical 
differential pressure gauge (or two separate pressure gauges) 
can be used instead of a differential pressure transducer. 
Under open circuit conditions, the first current electrode 60 
(FIG. 1) introduces an electrical current into the perfusion 
liquid flowing into the perfusion device 12. The electrical 
current flows into the perfusion device, where it emanates 
from the inlet portion 64 (FIG. 7) and flows across the trachea 
wall to the second current electrode 62. The first voltage 
sensing electrode 56 (FIG. 1) is in electrically continuity with 
the perfusion liquid in the trachea 14 (via cannula 78, tube 
100, and conduits 38 and 46) and therefore senses the elec 
trical potential inside the trachea. The second Voltage-sensing 
electrode 58 senses the electrical potential in the extraluminal 
bath 54 outside of the trachea. The amplifier 18 calculates the 
electrical potential difference between the Voltage-sensing 
electrodes 56,58, which represents the transepithelial poten 
tial difference of the trachea. The amplifier 18 can also cal 
culate the transepithelial impedance across the trachea wall 
based on the applied current and the measured potential dif 
ference. Hence, the apparatus 10 allows for simultaneous 
evaluation of Smooth muscles activity and bioelectric prop 
erties of the trachea, including the transepithelial potential 
difference and the transepithelial impedance. 
In an alternative approach, the apparatus 10 can be used in 
a “voltage clamp' (short circuit) mode where calibrated volt 
age pulses are applied to the electrodes 56,58 and the changes 
in short circuit current between electrodes 60, 62 are mea 
Sured to determine the transepithelial impedance across the 
trachea wall. 
In alternative embodiments, separate devices can be used 
measure Voltage, generate the electrical current, and/or mea 
Sure impedance. For example, separate electrometers can be 
used to measure Voltage, generate the electrical current, and 
measure impedance. Alternatively, an electrometer can be 
used measure Voltage and generate the electrical current, 
while a computer or other controller calculates impedance 
based on the Voltage and current. 
EXAMPLE 
Hartley guinea pigs were anesthetized by i.p. injection of 
Sodium pentobarbital (65 mg/kg). A 4.2-cm tracheal segment 
was removed and mounted on a perfusion device 12 at its in 
situ length. The perfusion device was placed in an extralumi 
nal bath containing a modified Krebs-Henseleit (OH) solu 
tion, and was perfused at 24 ml/min with MKH solution from 
an intraluminal bath. Water was used as a heat transfer fluid 
and was Supplied to the heat exchanger 20 and the outer 
jackets of vessels 26, 28 to maintain the temperature of the 
extraluminal and intraluminal baths at about 37° C. Current 
pulses (20 LA, 5 s duration, 50 s intervals) were delivered 
through the current electrodes, while the changes in the tran 
sepithelial potential difference (V) caused by the current 
pulses were monitored under open-circuit conditions. Alter 
natively, and as mentioned above, Voltage pulses can be 
applied across the Voltage electrodes under Voltage-clamp 
conditions, while the changes in short circuit current are 
monitored. 
The preparation was equilibrated for 2.5 hours to allow V, 
and the pressure drop (AP) to stabilize before the current 
pulses were delivered. Basal V, (the transepithelial voltage in 
the basal, or steady, state of an unstimulated epithelium) was 
14.8+0.8 mV. Relaxation responses of the smooth muscle 
were observed by pre-contracting the trachea with methacho 
line (MCh. 3x107M, ECs) in the extraluminal bath, which 
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effects of relaxant agents, when the mechanical and bioelec 
tric responses reached their plateau responses to MCh, the 
trachea was treated with agents added to the extraluminal or 
intraluminal bath. The agents used in this example are 
described in tables 1 and 2 below. The effects of the agents 
were analyzed Statistically using student’s paired t-test. 
P<0.05 was accepted as significant, and is indicated by an 
asterisk in FIGS. 8-15. The results are presented as 
means-SE. Each agent was tested four times. 
TABLE 1. 
Ion channel blockers 
5 
10 
V. NaCl and D-M caused depolarization (FIGS. 14C and 
14D) and relaxation (FIGS. 14A and 14B) in the presence 
MCh. FIGS.15A-15Darebar graphs summarizing the effects 
of NaCl and D-MonV, and R. Both osmolytes caused depo 
larization. NaCl decreased R, while D-M increased R. 
Because the tracheal segment remains intact and is not 
distorted in shape, the average basal V, was about twice as 
large as that measured in a conventional Ussing apparatus, 
which only provides V, and R, information in flattened tra 
cheal segments. Notably, the values obtained with the device 
Ion transport inhibitors 
Agents Amiloride NPPB Ouabain Bumetanide 
Conc. 3 x 10 M 104M 10 M 10 M 
(intraluminal) (intraluminal) (extraluminal) (extraluminal) 
Target Na C Na', K'- Na', K, 2CI 
channel channel pump cotransporter 
TABLE 2 
Receptor agonists Osmolytes 
Agents Histamine Terbutaline NaCl D-M 
Conc. 7.4 x 10 M 107M 3OOmoSM 3OOmoSM 
(extraluminal) (extraluminal) (intraluminal) (intraluminal) 
Target H f32 epithelium epithelium 
Amiloride, NPPB and bumetanide were dissolved in dim 
ethyl sulfoxide (DMSO) (with a final concentration equal to 
or less than 0.04%). The other agents were prepared in MKH. 
Terbutaline, histamine, ouabain and bumetanide were added 
to the extraluminal bath; the other agents were added to the 
intraluminal bath. Hypersmolar solutions were prepared by 
adding osmolytes to MKH solution. 
FIGS. 8A and 8B show the effects of amiloride and NPPB 
on V. Both agents caused depolarization of the epithelium, 
though depolarization caused by NPPB was slower to 
develop and greater in magnitude. Neither agent affected AP. 
FIGS. 9A-9D are bar graphs summarizing the effects of 
amiloride and NPPB on V, and R. The open bars in FIGS. 9A 
and 9C represent V, and R, before the agents were added. The 
depolarization caused by amiloride was accompanied by an 
increase in R, while NPPB had a negligible effect on R. 
FIGS. 10A-10D show the effects of ouabain and bumet 
anide on AP and V, Ouabain caused an immediate depolar 
ization (FIG. 10C) and a delayed contraction of the trachea 
(FIG. 10A). Bumetanide caused depolarization (FIG. 10D) 
and a small degree of relaxation of the trachea (FIG. 10B). 
FIGS. 11A-11D are bar graphs summarizing the effects of 
ouabain and bumetanide on V, and R. The depolarization 
caused by Ouabain was complete and was accompanied by a 
decrease in R. Bumetanide did not effect R. 
FIGS. 12A and 12D show the effects of histamine and 
terbutaline on AP and V. Histamine caused contraction (FIG. 
12A) and variable V, responses (FIG. 12C). Terbutaline 
caused relaxation (FIG. 12B) and transient depolarization in 
three of the four preparations followed by slow hyperpolar 
ization (FIG. 12D). FIGS. 13 A-13D are bar graphs summa 
rizing the effects of histamine and terbutaline on V, and R. On 
average, histamine and terbutaline did not effect V, apprecia 
bly. Both agents did not effect R. 
FIGS. 14A-14D show the effects of hyperosmolarity elic 








more closely represent the actual value of V, in a live animal 
than that which can be obtained using a conventional Ussing 
preparation. 
In view of the many possible embodiments to which the 
principles of the disclosed invention may be applied, it should 
be recognized that the illustrated embodiments are only pre 
ferred examples of the invention and should not be taken as 
limiting the scope of the invention. Rather, the scope of the 
invention is defined by the following claims. We therefore 
claim as our invention all that comes within the scope and 
spirit of these claims. 
We claim: 
1. An apparatus for measuring physiological characteris 
tics of an intact trachea in vitro, comprising: 
a perfusion device configured to flow a perfusion liquid 
through the trachea: 
a differential pressure device operable to measure a pres 
sure difference of the perfusion liquid flowing through 
the trachea: 
a set of current electrodes comprising at least a first current 
electrode and a second current electrode operable to pass 
an applied current through the epithelium of the trachea 
between the first and second current electrodes; and 
a set of Voltage-sensing electrodes comprising at least a 
first Voltage-sensing electrode and a second Voltage 
sensing electrode operable to detect a transepithelial 
potential difference between the Voltage-sensing elec 
trodes; 
a vessel containing an extraluminal bath and adapted to 
receive the trachea in the bath; 
wherein the first voltage electrode is in electrical continuity 
with the perfusion liquid flowing and the second Voltage 
electrode is disposed in the extraluminal bath; and 
wherein the first current electrode is in electrical continuity 
with the perfusion liquid and the second current elec 
trode is disposed in the extraluminal bath 
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wherein the second current electrode completely surrounds 
the perfusion device and the second Voltage electrode. 
2. The apparatus of claim 1, wherein the second current 
electrode comprises a metal screen. 
3. The apparatus of claim 1, wherein the perfusion device 
comprises: 
an inlet portion adapted to introduce the perfusion liquid 
into a first end of the trachea and an outlet portion 
adapted to receive the perfusion liquid flowing out 
wardly from a second end of the trachea: 
a first, inlet conduit in fluidic communication with the inlet 
portion and adapted to introduce the perfusion liquid 
into the inlet portion; 
a second conduit in fluidic communication with the inlet 
portion and fluidly connected to the differential pressure 
device for measuring the pressure of the perfusion liquid 
flowing from the inlet portion and into the trachea: 
a third, outlet conduit in fluidic communication with the 
outlet portion and adapted receive the perfusion liquid 
flowing from the outlet portion; 
a fourth conduit in fluidic communication with the outlet 
portion and fluidly connected to the differential pressure 
device for measuring the pressure of the perfusion liquid 
flowing from the trachea and into the outlet portion. 
4. The apparatus of claim 3, further comprising: 
wherein the first current electrode is in electrical continuity 
with the perfusion liquid flowing through the first con 
duit; and 
wherein the first voltage electrode is in electrical continuity 
with the perfusion liquid in the second conduit. 
5. The apparatus of claim 3, wherein the perfusion device 
further comprises: 
an inlet cannula having a lumen, a proximal end portion in 
the inlet portion and a distal end portion extending out 
wardly from the inlet portion and adapted to extend into 
the first end of the trachea, the distal end portion having 
at least one opening; 
an outlet cannula spaced from and aligned with the inlet 
cannula, the outlet cannula having a lumen, a proximal 
end portion in the outlet portion and a distal end portion 
extending outwardly from the outlet portion and adapted 
to extend into the second end of the trachea, the distal 
end portion having at least one opening; 
wherein the first conduit and the inlet portion define an inlet 
flow path for the perfusion liquid between an outer sur 
face of the inlet cannula and an inner Surface of inlet 
portion; 
wherein the second conduit is in fluidic communication 
with the lumen of the inlet cannula at the proximal end 
thereof and the differential pressure device; 
wherein the third conduit and the outlet portion define an 
outlet flow path for the perfusion liquid between an outer 
Surface of the outlet cannula and an inner Surface of the 
outlet portion; 
wherein the fourth conduit is in fluidic communication 
with the lumen of the outlet cannula at the proximal end 
thereof and the differential pressure device; and 
wherein the differential pressure device measures the pres 
sure difference of the perfusion liquid between the open 
ing in the distal end portion of the inlet cannula and the 
opening in the distal end portion of the outlet cannula. 
6. The apparatus of claim 1, further comprising Voltage 
measuring means for measuring the transepithelial potential 
difference between the voltage electrodes. 
7. The apparatus of claim 6, further comprising current 















8. The apparatus of claim 7, wherein the Voltage-measuring 
means and the current-generating means comprise a Voltage/ 
current clamp amplifier. 
9. An apparatus for measuring physiological characteris 
tics of an intact trachea in vitro, comprising: 
means for perfusing a perfusion liquid through the trachea: 
means for measuring a pressure difference of the perfusion 
liquid flowing through the trachea: 
means for passing a current through the wall of the trachea: 
means for measuring a transepithelial potential difference 
of the trachea; and 
means for determining the impedance of the trachea based 
on the current and the transepithelial potential differ 
ence, 
wherein the means for measuring a transepithelial potential 
difference of the trachea comprises a first voltage-sens 
ing electrode in electrical continuity with the perfusion 
liquid and a second Voltage-sensing electrode disposed 
in a liquid Surrounding the trachea: 
wherein the means for passing a current through the wall of 
the trachea comprises a first current electrode in electri 
cal continuity with the perfusion liquid and a second 
current electrode disposed in the liquid Surrounding the 
trachea, the second current electrode completely Sur 
rounding the second Voltage-sensing electrode. 
10. The apparatus of claim 9, wherein the means for mea 
Suring a transepithelial potential difference of the trachea 
further comprises a Voltage-measuring device operable to 
measure the transepithelial potential difference by measuring 
the potential difference between the Voltage-sensing elec 
trodes. 
11. The apparatus of claim 10, wherein the means for 
passing a current through the wall of the trachea further 
comprises a current generator operable to generate and cause 
the current to flow from the first current electrode through the 
trachea wall to the second current electrode. 
12. The apparatus of claim 11, wherein the second current 
electrode comprises a metal screen completely surrounding 
the second Voltage-sensing electrode. 
13. The apparatus of claim 9, wherein the means for per 
fusing a perfusion liquid through the trachea comprises a 
perfusion circuit that circulates a perfusion liquid through the 
trachea, the perfusion circuit comprising a trachea-mounting 
mechanism that includes an inlet portion and an outlet por 
tion, wherein the inlet portion is adapted to be secured to a 
first end of the trachea and the outlet portion is adapted to be 
secured to a second end of the trachea Such that circulating 
perfusion liquid can flow into the trachea via the inlet portion 
and out of the trachea via the outlet portion. 
14. A method for measuring physiological characteristics 
of an intact trachea in vitro, comprising: 
flowing a perfusion liquid through the trachea: 
measuring a transepithelial potential difference of the tra 
chea: 
passing an electrical signal through the wall of the trachea: 
and 
measuring an electrical impedance of the trachea: 
wherein the trachea is placed in an extraluminal bath; 
wherein measuring the transepithelial potential difference 
comprises measuring the electrical potential between 
first and second Voltage-sensing electrodes, the first 
Voltage-sensing electrode being in electrical continuity 
with the perfusion liquid flowing into the trachea and the 
second Voltage-sensing electrode is disposed in the 
extraluminal bath; 
wherein passing an electrical signal through the wall of the 
trachea comprises placing a first current electrode in 
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electrical continuity with the perfusion liquid flowing 
into the trachea, placing a second current electrode in the 
extraluminal bath such that the second current electrode 
completely Surrounds the second Voltage-sensing elec 
trode, and applying the electrical signal to the first cur 
rent electrode such that the electrical signal is transmit 
ted through the trachea wall to the second current 
electrode. 
15. The method of claim 14, further comprising measuring 
a pressure difference of the perfusion liquid flowing through 
the trachea. 
16. The method of claim 15, wherein the transepithelial 
potential difference, the electrical impedance, and the pres 
Sure difference are measured simultaneously. 
17. The method of claim 14, further comprising: 
adding an agent to the perfusion liquid; and 
determining the change in the transepithelial potential dif 
ference and the electrical impedance caused by the addi 
tion of the agent. 
18. The method of claim 17, further comprising: 
prior to adding the agent to the perfusion liquid, measuring 
a pressure difference of the perfusion liquid flowing 
through the trachea; and 
determining the change in the pressure difference caused 
by the addition of the agent. 
19. The method of claim 14, further comprising: 
adding an agent to the extraluminal bath; and 
determining the change in the transepithelial potential dif 
ference and the electrical impedance caused by the addi 
tion of the agent. 
20. The method of claim 19, further comprising: 
prior to adding the agent to the extraluminal bath, measur 
ing a pressure difference of the perfusion liquid flowing 
through the trachea; and 
determining the change in the pressure difference caused 
by the addition of the agent. 
21. An apparatus for measuring physiological characteris 
tics of an intact trachea in vitro, comprising: 
a perfusion device configured to flow a perfusion liquid 
through the trachea: 
a vessel containing an extraluminal bath and adapted to 








a differential pressure device operable to measure a pres 
sure difference of the perfusion liquid flowing through 
the trachea: 
a set of Voltage-sensing electrodes comprising a first Volt 
age-sensing electrode in electrical continuity with the 
perfusion liquid and a second Voltage-sensing electrode 
disposed in the extraluminal bath; 
a Voltage-measuring device operable to measure a transepi 
thelial potential difference of the trachea by measuring 
electrical potential between the Voltage-sensing elec 
trodes; 
a set of current electrodes comprising a first current elec 
trode in electrical continuity with the perfusion liquid 
and a second current electrode disposed in the extralu 
minal bath and completely Surrounding the trachea and 
the second Voltage-sensing electrode; and 
a current generator connected to the current electrodes and 
operable to generate a current that passes through the 
epithelium of the trachea between the first and second 
current electrodes. 
22. The apparatus of claim 21, wherein the perfusion 
device comprises: 
an inlet portion adapted to be secured to a first end of the 
trachea and an outlet portion adapted to be secured to a 
second end of the trachea So that perfusion liquid can 
flow into the first end of the trachea via the inlet portion 
and out of the second end of the trachea via the outlet 
portion; 
a first, inlet conduit in fluidic communication with the inlet 
portion for introducing the perfusion liquid into the inlet 
portion and the trachea: 
a second conduit in fluidic communication with the inlet 
portion and the differential pressure device for measur 
ing the pressure of the perfusion liquid at a first location 
in the trachea: 
a third, outlet conduit in fluidic communication with the 
outlet portion and adapted receive the perfusion liquid 
from the outlet portion; 
a fourth conduit in fluidic communication with the outlet 
portion and the differential pressure device for measur 
ing the pressure of the perfusion liquid at a second loca 
tion in trachea downstream of the first location. 
k k k k k 
